$CWBC
Community West Bancshares Stock $cwbc

$cwbc Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000112737120000065 Filed on May 06, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$16.51M	$16.29M
YoY Change	1.33%	3.55%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.180M	$1.860M
YoY Change	-36.56%	-22.5%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$477.0K	$454.0K
YoY Change	5.07%	49.34%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$9.117M	$7.169M
YoY Change	27.17%	4.98%
Income Tax	$2.494M	$1.953M
% Of Pretax Income	27.36%	27.24%
Net Earnings	$6.623M	$5.216M
YoY Change	26.97%	5.06%
Net Earnings / Revenue	40.12%	32.02%
Basic Earnings Per Share	$0.52	$0.38
Diluted Earnings Per Share	$0.52	$0.38
COMMON SHARES
Basic Shares Outstanding	12.73M shares	13.65M shares
Diluted Shares Outstanding	12.78M shares	13.76M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$36.16M	$32.24M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$7.410M	$8.096M
YoY Change	-8.47%	-14.14%
Goodwill	$53.78M	$53.78M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.619B	$1.564B
YoY Change	3.48%	-3.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$44.20M	$32.10M
YoY Change	37.69%	68.95%
Accrued Expenses	$6.100M	$8.100M
YoY Change	-24.69%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$44.20M	$32.10M
YoY Change	37.69%	68.95%
LONG-TERM LIABILITIES
Long-Term Debt	$5.200M	$5.200M
YoY Change	0.0%	0.0%
Other Long-Term Liabilities	$9.300M	$10.40M
YoY Change	-10.58%	46.48%
Total Long-Term Liabilities	$5.200M	$5.200M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.20M	$32.10M
Total Long-Term Liabilities	$5.200M	$5.200M
Total Liabilities	$1.400B	$1.337B
YoY Change	4.73%	-5.53%
SHAREHOLDERS EQUITY
Retained Earnings	$141.1M	$124.1M
YoY Change	13.7%	15.43%
Common Stock	$78.85M	$102.4M
YoY Change	-22.99%	-1.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$218.7M	$227.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.619B	$1.564B
YoY Change	3.48%	-3.62%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$6.623M	$5.216M
YoY Change	26.97%	5.06%
Depreciation, Depletion And Amortization	$1.180M	$1.860M
YoY Change	-36.56%	-22.5%
Cash From Operating Activities	$5.931M	$6.902M
YoY Change	-14.07%	8.71%
INVESTING ACTIVITIES
Capital Expenditures	$32.00K	$133.0K
YoY Change	-75.94%	-70.9%
Acquisitions
YoY Change
Other Investing Activities	-$27.42M	-$10.46M
YoY Change	162.14%	-63.82%
Cash From Investing Activities	-$27.45M	-$10.59M
YoY Change	159.27%	-63.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$11.05M	$1.874M
YoY Change	489.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$5.111M	$4.195M
YoY Change	21.84%	-111.94%
NET CHANGE
Cash From Operating Activities	$5.931M	$6.902M
Cash From Investing Activities	-$27.45M	-$10.59M
Cash From Financing Activities	$5.111M	$4.195M
Net Change In Cash	-$16.41M	$508.0K
YoY Change	-3330.71%	-100.87%
FREE CASH FLOW
Cash From Operating Activities	$5.931M	$6.902M
Capital Expenditures	$32.00K	$133.0K
Free Cash Flow	$5.899M	$6.769M
YoY Change	-12.85%	14.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	191000	USD
CY2020Q1	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	294000	USD
CY2019Q1	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	200000	USD
CY2020Q1	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	338000	USD
CY2019Q4	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	30187000	USD
CY2020Q1	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	44227000	USD
CY2019Q4	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	32148000	USD
CY2020Q1	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	33828000	USD
CY2019Q4	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	1182000	USD
CY2020Q1	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	-558000	USD
CY2020Q1	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis	200677000	USD
CY2020Q1	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue	205254000	USD
CY2019Q1	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	-163000	USD
CY2020Q1	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	-36000	USD
CY2019Q1	cvcy	Directors Expenses DirectorsExpenses	176000	USD
CY2020Q1	cvcy	Directors Expenses DirectorsExpenses	192000	USD
CY2019Q1	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	121000	USD
CY2020Q1	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	107000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	928218000	USD
CY2019Q1	us-gaap	Occupancy Net OccupancyNet	1479000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	1144000	USD
CY2020Q1	cvcy	Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis	20	quarter
CY2019Q4	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	38000	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	942000	USD
CY2019Q1	cvcy	Loan Placement Fees LoanPlacementFees	139000	USD
CY2020Q1	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	21196000	USD
CY2020Q1	cvcy	Loan Placement Fees LoanPlacementFees	299000	USD
CY2019Q4	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	143000	USD
CY2020Q1	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2020Q1	cvcy	Loansand Leases Receivable Allowance Numberof Components LoansandLeasesReceivableAllowanceNumberofComponents	2	component
CY2019Q1	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	9167000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	121000	USD
CY2019Q1	us-gaap	Advertising Expense AdvertisingExpense	202000	USD
CY2020Q1	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	193000	USD
CY2019Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2019Q1	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	0	USD
CY2020Q1	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	64000	USD
CY2019Q1	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	8420000	USD
CY2020Q1	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	-644000	USD
CY2019Q1	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	9702000	USD
CY2020Q1	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	1464000	USD
CY2019Q1	cvcy	Information Technology InformationTechnology	777000	USD
CY2020Q1	cvcy	Information Technology InformationTechnology	608000	USD
CY2019Q1	cvcy	Interchange Fees InterchangeFees	343000	USD
CY2020Q1	cvcy	Interchange Fees InterchangeFees	333000	USD
CY2019Q1	cvcy	Internet Banking Expense InternetBankingExpense	194000	USD
CY2020Q1	cvcy	Internet Banking Expense InternetBankingExpense	196000	USD
CY2019Q1	cvcy	Purchases Of Available For Sale Securities Not Yet Settled PurchasesOfAvailableForSaleSecuritiesNotYetSettled	1816000	USD
CY2020Q1	cvcy	Purchases Of Available For Sale Securities Not Yet Settled PurchasesOfAvailableForSaleSecuritiesNotYetSettled	12718000	USD
CY2019Q1	cvcy	Regulatory Assessments RegulatoryAssessments	152000	USD
CY2020Q1	cvcy	Regulatory Assessments RegulatoryAssessments	47000	USD
CY2019Q1	cvcy	Service Charges ServiceCharges	690000	USD
CY2020Q1	cvcy	Service Charges ServiceCharges	646000	USD
CY2020Q1	cvcy	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	5	plan
CY2020Q1	cvcy	Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	10000	USD
CY2020Q1	cvcy	Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	0.1
CY2020Q1	cvcy	Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	P12M
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001127371
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12475439	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CENTRAL VALLEY COMMUNITY BANCORP
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	us-gaap	Advertising Expense AdvertisingExpense	173000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	143000	USD
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2817000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31727000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1328000	USD
CY2019Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1335000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32235000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52574000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	121000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2019Q4	us-gaap	Assets Assets	1596755000	USD
CY2020Q1	us-gaap	Assets Assets	1618646000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	524829000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	470746000	USD
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	522943000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	8688000	USD
CY2020Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9904000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	3999000	USD
CY2020Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	-1886000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4689000	USD
CY2020Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11790000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	466747000	USD
CY2020Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	524829000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	23097000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	24616000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1577000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1705000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	176003000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	178933000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	470746000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	522943000	USD
CY2019Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7472000	USD
CY2020Q1	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7592000	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1099000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4198000	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	47000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2019Q1	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	1052000	USD
CY2020Q1	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	4198000	USD
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	30230000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	29945000	USD
CY2019Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	171000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	182000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52574000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36162000	USD
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	24195000	USD
CY2020Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	22713000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	78854000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10545000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2478000	USD
CY2019Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	1052000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	4198000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36162000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	88855000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	72000	USD
CY2019Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	94692000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	508000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16412000	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13754965	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13301395	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13754965	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13301395	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	89379000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2213000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	5386000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	159032000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	189368000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2476000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6404000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	247887000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	284060000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4689000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	11790000	USD
CY2019Q4	us-gaap	Deposits Deposits	1333285000	USD
CY2020Q1	us-gaap	Deposits Deposits	1350591000	USD
CY2019Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	521000	USD
CY2020Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	240000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1372000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1408000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	17000	USD
CY2020Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	912105000	USD
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	3734000	USD
CY2020Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	16113000	USD
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	2362000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	15085000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q1	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2019Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	6062000	USD
CY2020Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	6062000	USD
CY2018Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9104000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9118000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9130000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10546000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	9090000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	10352000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	40000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	194000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	48000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	84000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	9000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	43000	USD
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	938131000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	941081000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	926882000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1693000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1115000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	784000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	1336000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1878000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1704000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	53777000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	5851000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	6750000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	48000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	217000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	3734000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	16113000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	40000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	194000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	4305000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	16449000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	4046000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	2193000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	29000	USD
CY2019Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	92000	USD
CY2020Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	120000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	15000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	2230000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	2018000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	2796000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	2351000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	1805000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	4557000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	19000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	202000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	1504000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	14095000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	1509000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	14098000	USD
CY2020Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7169000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9117000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1953000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2494000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	218000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	612000	USD
CY2019Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	1099000	USD
CY2020Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-3890000	USD
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	109126	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	44125	shares
CY2019Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	395000	USD
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	336000	USD
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16289000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16506000	USD
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12554000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12898000	USD
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	738658000	USD
CY2020Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	746593000	USD
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	28379000	USD
CY2020Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	13449000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	454000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	477000	USD
CY2019Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	393000	USD
CY2020Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	432000	USD
CY2019Q1	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	57000	USD
CY2020Q1	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	45000	USD
CY2019Q1	us-gaap	Interest Expense Other InterestExpenseOther	4000	USD
CY2020Q1	us-gaap	Interest Expense Other InterestExpenseOther	0	USD
CY2019Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	150000	USD
CY2020Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	183000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	24000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	934250000	USD
CY2019Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	15860000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	14654000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15835000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16029000	USD
CY2019Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	562000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	159000	USD
CY2019Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3023000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3266000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	425000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	502000	USD
CY2019Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2020Q1	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6490000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7512000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1368627000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	1399973000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1596755000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1618646000	USD
CY2019Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	171000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	182000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9130000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10546000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	943380000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	929769000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0	USD
CY2019Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	32000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	919223000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4195000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5111000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10589000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27454000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6902000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5931000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	5216000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	6623000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5216000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6623000	USD
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	594627000	USD
CY2020Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	603998000	USD
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	11667000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	12078000	USD
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	2976000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	6541000	USD
CY2019Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	460000	USD
CY2020Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	776000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	941865000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11052000	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1372000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	545000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1408000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	65253000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	155742000	USD
CY2019Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	1000000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	559000	USD
CY2020Q1	us-gaap	Other Commitment OtherCommitment	2289000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5329000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-4145000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	7566000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-5885000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5329000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4145000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1052000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4198000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	311000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1241000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2237000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1740000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	8618000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1687000	USD
CY2019Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1110000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	944000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	3239000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-13616000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1874000	USD
CY2020Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32000	USD
CY2020Q1	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	89967000	USD
CY2019Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2020Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	1370000	USD
CY2020Q1	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	0	USD
CY2019Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	14000000	USD
CY2019Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2020Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	531000	USD
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6051000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	8136000	USD
CY2020Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	52985000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	106037000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	52985000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	106037000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	95000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	207000	USD
CY2019Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	80000	USD
CY2020Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	58000	USD
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	327000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	458000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7618000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7410000	USD
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-25000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1375000	USD
CY2019Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-25000	USD
CY2020Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1375000	USD
CY2019Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	17000000	USD
CY2020Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	0	USD
CY2019Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1370000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	100000	USD
CY2020Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	135932000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	141147000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10129000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	143000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	121000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	167000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	349000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	400	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.02
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	343000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	121120	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	88990	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.73
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.51
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	343000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	88990	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.51
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	343000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	88990	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.51
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.54
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y0M20D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y0M20D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y0M20D
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31730	shares
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	141000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	80000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	58000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	95000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	207000	USD
CY2019Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1874000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11052000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	219738000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	227455000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	228128000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	218673000	USD
CY2019Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	1515000	USD
CY2020Q1	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	1551000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13755615	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12779096	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13646489	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12734971	shares
CY2020Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No customer accounts for more than 10 percent of revenues for the Company or the Bank.</font></div></div>

Files In Submission

Name	View Source	Status
R36.htm	Edgar Link	pending
0001127371-20-000065-index-headers.html	Edgar Link	pending
0001127371-20-000065-index.html	Edgar Link	pending
0001127371-20-000065.txt	Edgar Link	pending
0001127371-20-000065-xbrl.zip	Edgar Link	pending
cvcy-20200331.xml	Edgar Link	completed
cvcy-20200331.xsd	Edgar Link	pending
cvcy-2020033110xqq1.htm	Edgar Link	pending
cvcy-20200331_cal.xml	Edgar Link	unprocessable
cvcy-20200331_def.xml	Edgar Link	unprocessable
cvcy-20200331_lab.xml	Edgar Link	unprocessable
cvcy-20200331_pre.xml	Edgar Link	unprocessable
exhibit1086amendedsalaryco.htm	Edgar Link	pending
exhibit1087amendedsplitdol.htm	Edgar Link	pending
exhibit1088salarycontinuat.htm	Edgar Link	pending
exhibit1089splitdollaragre.htm	Edgar Link	pending
exhibit10903rdamendedsalar.htm	Edgar Link	pending
exhibit10913rdamendedsplit.htm	Edgar Link	pending
exhibit3112020q1.htm	Edgar Link	pending
exhibit3122020q1.htm	Edgar Link	pending
exhibit3212020q1.htm	Edgar Link	pending
exhibit3222020q1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBC
Community West Bancshares Stock $cwbc

2020 Q1 Form 10-Q Financial Statement

#000112737120000065 Filed on May 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC Community West Bancshares Stock $cwbc

2020 Q1 Form 10-Q Financial Statement

#000112737120000065 Filed on May 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC
Community West Bancshares Stock $cwbc